These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 32524661)

  • 21. [Lymphocyte activation markers in patients with ovarian cancer].
    Nowicka A; Rogala E; Bednarek W; Barczyński B; Wertel I; Piekarczyk W; Kotarski J
    Ginekol Pol; 2012 Oct; 83(10):737-43. PubMed ID: 23383558
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Correlation of NK T-like CD3+CD56+ cells and CD4+CD25+(hi) regulatory T cells with VEGF and TNFalpha in ascites from advanced ovarian cancer: Association with platinum resistance and prognosis in patients receiving first-line, platinum-based chemotherapy.
    Bamias A; Koutsoukou V; Terpos E; Tsiatas ML; Liakos C; Tsitsilonis O; Rodolakis A; Voulgaris Z; Vlahos G; Papageorgiou T; Papatheodoridis G; Archimandritis A; Antsaklis A; Dimopoulos MA
    Gynecol Oncol; 2008 Feb; 108(2):421-7. PubMed ID: 18036640
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Phenotype of lymphocyte in ovarian tumor peritoneal fluid. A preliminary study.
    Lacki J; Markowska J; Wiktorowicz K
    Eur J Gynaecol Oncol; 1992; 13(6):475-9. PubMed ID: 1473526
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Ascitic fluid-associated lymphocytes in patients with metastatic ovarian cancer. Analysis of lymphocyte subsets and of phenotypical changes induced by "in vitro".
    Loiudice L; Dell'Osso A; Loria MP; D'Ambra PP; Lasaracina E; Crollo E; Lucivero G
    Eur J Gynaecol Oncol; 1995; 16(4):301-6. PubMed ID: 7556288
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Expression of costimulatory molecules CD80 and CD86 and their receptors CD28, CTLA-4 on malignant ascites CD3+ tumour-infiltrating lymphocytes (TIL) from patients with ovarian and other types of peritoneal carcinomatosis.
    Melichar B; Nash MA; Lenzi R; Platsoucas CD; Freedman RS
    Clin Exp Immunol; 2000 Jan; 119(1):19-27. PubMed ID: 10606960
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Peritoneal immune system in patients with advance epithelial ovarian cancer.
    Wertel I; Nowicka A; Rogala E; Kotarski J
    Int Rev Immunol; 2011; 30(2-3):87-101. PubMed ID: 21557636
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Ovarian cancer-associated ascites demonstrates altered immune environment: implications for antitumor immunity.
    Giuntoli RL; Webb TJ; Zoso A; Rogers O; Diaz-Montes TP; Bristow RE; Oelke M
    Anticancer Res; 2009 Aug; 29(8):2875-84. PubMed ID: 19661290
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Identification of myeloid dendritic cells in peritoneal fluid by flow cytometry].
    Wertel I; Roliński J; Gogacz M; Tabarkiewicz J; Kotarski J
    Ginekol Pol; 2003 Feb; 74(2):116-20. PubMed ID: 12715420
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Profound elevation of CD8+ T cells expressing the intraepithelial lymphocyte marker CD103 (alphaE/beta7 Integrin) in high-grade serous ovarian cancer.
    Webb JR; Wick DA; Nielsen JS; Tran E; Milne K; McMurtrie E; Nelson BH
    Gynecol Oncol; 2010 Sep; 118(3):228-36. PubMed ID: 20541243
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Induction of T cell responses against autologous ovarian cancer by anti-idiotype minibody-pulsed dendritic cells].
    Yang WL; Cui H; Feng J; Chang XH; Fu TY; Ye X; Zhang H; Li XP; Wen HW; Feng LM; Tong CR
    Ai Zheng; 2004 Dec; 23(12):1639-45. PubMed ID: 15601552
    [TBL] [Abstract][Full Text] [Related]  

  • 31. CA125 in peritoneal fluid of ovarian cancer patients.
    Vergote IB; Onsrud M; Børmer OP; Sert BM; Moen M
    Gynecol Oncol; 1992 Feb; 44(2):161-5. PubMed ID: 1544593
    [TBL] [Abstract][Full Text] [Related]  

  • 32. NKp46+ Innate Lymphoid Cells Dampen Vaginal CD8 T Cell Responses following Local Immunization with a Cholera Toxin-Based Vaccine.
    Luci C; Bekri S; Bihl F; Pini J; Bourdely P; Nouhen K; Malgogne A; Walzer T; Braud VM; Anjuère F
    PLoS One; 2015; 10(12):e0143224. PubMed ID: 26630176
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Efficacy of ascitic fluid cell block for diagnosing primary ovarian, peritoneal, and tubal cancer in patients with peritoneal carcinomatosis with ascites.
    Uehara T; Yoshida H; Fukuhara M; Yoshida M; Motoi N; Sugawara S; Sone M; Arai Y; Tamura K; Uno M; Ishikawa M; Kato T
    Gynecol Oncol; 2020 May; 157(2):398-404. PubMed ID: 32063274
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Dendritic cell subsets in the peritoneal fluid and peripheral blood of women suffering from ovarian cancer.
    Wertel I; Polak G; Bednarek W; Barczyński B; Roliński J; Kotarski J
    Cytometry B Clin Cytom; 2008 Jul; 74(4):251-8. PubMed ID: 18302193
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Lymphokine-activated killer activity of tumor-associated and peripheral blood lymphocytes isolated from patients with ascites ovarian tumors.
    Allavena P; Zanaboni F; Rossini S; Merendino A; Bonazzi C; Vassena L; Mangioni C; Mantovani A
    J Natl Cancer Inst; 1986 Oct; 77(4):863-8. PubMed ID: 3489856
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Lymphocytes isolated from the peritoneal fluid of women with advanced ovarian carcinoma differ significantly from autologous peripheral blood lymphocytes.
    Melioli G; Ferrari I; Casartelli G; Ragni N
    Gynecol Oncol; 1993 Mar; 48(3):301-7. PubMed ID: 8462898
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Natural killer activity of lymphoid cells isolated from human ascitic ovarian tumors.
    Mantovani A; Allavena P; Sessa C; Bolis G; Mangioni C
    Int J Cancer; 1980 May; 25(5):573-82. PubMed ID: 6154662
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Without prior stimulation, tumor-associated lymphocytes from malignant effusions lyse autologous tumor cells in the presence of bispecific antibody HEA125xOKT3.
    Strauss G; Gückel B; Wallwiener D; Moldenhauer G
    Clin Cancer Res; 1999 Jan; 5(1):171-80. PubMed ID: 9918216
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Induction of ovarian tumor-specific CD8+ cytotoxic T lymphocytes by acid-eluted peptide-pulsed autologous dendritic cells.
    Santin AD; Bellone S; Ravaggi A; Pecorelli S; Cannon MJ; Parham GP
    Obstet Gynecol; 2000 Sep; 96(3):422-30. PubMed ID: 10960637
    [TBL] [Abstract][Full Text] [Related]  

  • 40. FACS analysis of peritoneal lymphocytes in ovarian cancer and control patients.
    Reijnhart RM; Bieber MM; Teng NN
    Immunobiology; 1994 Aug; 191(1):1-8. PubMed ID: 7806256
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.